Subjective symptoms
|
Absent
|
Eye and airway irritation
|
Sensory irritation-URT
|
Absent
|
Marked
|
Bronchial airway injury
|
Minimal, if any
|
Marked
|
Surfactant deterioration
|
Marked
|
Dose-dependent
|
Sensory irritation-LRT
|
Marked
|
Dose-dependent
|
Alveolar macrophage injury
|
Marked
|
Dose-dependent
|
Pulmonary vascular dysfunction
|
Marked
|
Dose-dependent
|
Cardiopulmonary dysfunction
|
Marked
|
Marked
|
Early lung edema
|
Extreme doses
|
Dose-dependent
|
Onset of lung edema
|
Maximum 15–20 h
|
Instant
|
Primary countermeasure
|
Lung edema
|
Lung edema & obliterating airway injury
|
Secondary countermeasure
|
Rapid recovery
|
Lingering airway injury
|
Clinical guidance on inhaled dose
|
Phosgene dosimeters
|
Environmental analyses (if available)
|
Prognostic approaches
|
Hemoglobin, eNO, eCO2
|
Irritation severity, fibrin
|